SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001933414-23-000087
Filing Date
2023-11-07
Accepted
2023-11-07 17:12:53
Documents
53
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mlys-20230930.htm   iXBRL 10-Q 703161
2 EX-31.1 mlys-3q2310qex311.htm EX-31.1 9816
3 EX-31.2 mlys-3q2310qex312.htm EX-31.2 9753
4 EX-32.1 mlys-3q2310qex321.htm EX-32.1 5057
5 EX-32.2 mlys-3q2310qex322.htm EX-32.2 4961
  Complete submission text file 0001933414-23-000087.txt   3750092

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mlys-20230930.xsd EX-101.SCH 24848
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mlys-20230930_cal.xml EX-101.CAL 32853
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mlys-20230930_def.xml EX-101.DEF 155403
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mlys-20230930_lab.xml EX-101.LAB 400260
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mlys-20230930_pre.xml EX-101.PRE 267396
47 EXTRACTED XBRL INSTANCE DOCUMENT mlys-20230930_htm.xml XML 340202
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Filer) CIK: 0001933414 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41614 | Film No.: 231385046
SIC: 2834 Pharmaceutical Preparations